Transgenic chickens producing exogenous protein in eggs
View Patent ↗This invention provides vectors and methods for the stable introduction of exogenous nucleic acid sequences into the genome of a bird and for expressing said exogenous sequences to alter the phenotype of the bird or to produce desired proteins. In particular, transgenic chickens are produced which express exogenous sequences in their oviducts. Eggs which contain exogenous proteins are also produced.
1. A germline transgenic chicken that contains a replication-deficient vector derived from an avian leukosis virus, wherein the vector comprises a transgene that encodes an exogenous protein, wherein the exogenous protein is expressed in oviduct magnum tubular gland cells of the chicken and is secreted into an egg of the chicken at a detectable level.
2. The germline transgenic chicken of claim 1 wherein the exogenous protein is present in egg white of the egg.
3. The germline transgenic chicken of claim 1 wherein the exogenous protein is an enzyme.
4. A germline transgenic chicken that contains a replication-deficient vector derived from an avian leukosis virus, wherein the vector comprises a transgene which encodes a pharmaceutical protein, wherein the pharmaceutical protein is and expressed in oviduct magnum tubular gland cells of the chicken and is secreted into an egg of the chicken at a detectable level.
5. The germline transgenic chicken of claim 4 wherein the pharmaceutical protein is present in egg white of the egg.
6. The germline transgenic chicken of claim 4 wherein the protein is selected from the group consisting of antitrypsin, antithrombin III, collagen, factors VIII, IX, X, fibrinogen, insulin, lactoferrin, protein C, tissue-type plasminogen activator, somatotrophin, cytokine, antibody, human growth hormone, immunotoxin and chymotrypsin.
7. A germline transgenic chicken that contains a replication-deficient vector derived from an avian leukosis virus, wherein the vector comprises a transgene which encodes a cytokine wherein the cytokine is expressed in oviduct magnum tubular gland cells of the chicken and is secreted into an egg of the chicken at a detectable level.
8. The germline transgenic chicken of claim 7 wherein the cytokine is granulocyte macrophage colony-stimulating factor (GM-CSF).
9. The germline transgenic chicken of claim 7 wherein the cytokine is granulocyte colony-stimulating factor (G-CSF).
10. The germline transgenic chicken of claim 7 wherein the cytokine is erythropoietin.
11. The germline transgenic chicken of claim 7 wherein the cytokine is interferon.
12. A germline transgenic chicken that contains a replication-deficient vector derived from an avian leukosis virus, wherein the vector comprises a transgene which encodes an antibody wherein the antibody is expressed in oviduct magnum tubular gland cells of the chicken and is secreted into an egg of the chicken at a detectable level.
13. The germline transgenic chicken of claim 12 wherein the antibody is present in egg white of the egg.
14. A germline transgenic chicken that contains a replication-deficient vector derived from an avian leukosis virus, wherein the vector comprises a transgene which encodes an immunotoxin wherein the immunotoxin is expressed in oviduct magnum tubular gland cells of the chicken and is secreted into an egg of the chicken at a detectable level.
15. A germline transgenic chicken that contains a replication-deficient vector derived from an avian leukosis virus, wherein the vector comprises a transgene which encodes an exogenous protein, wherein the exogenous protein is expressed in oviduct magnum tubular gland cells of the chicken and is secreted into egg white of the chicken at a detectable level.
16. The germline transgenic chicken of claim 15 wherein the chicken is a founder.
17. The germline transgenic chicken of claim 15 wherein the exogenous protein is an enzyme.